Please enter your username and password below, if you are not yet a member of Oncology Central remember you can register for free.
Already have an account? Login here
Categories // Events Coverage
Two studies, due to be presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting I (27–28 April 2020), have suggested promising conclusions relating to the use of circulating tumor DNA (ctDNA) for early detection and prevention of cancer. Read the full summaries below.
It's completely free
Written ByRachel Jenkins, Future Science Group
Updated 28 April, 2020